Genomics Outlook for Disruption Is Rising
“For cancer treatment, living drugs enabled by genetic editing, are forecast to reach a $200B addressable market by 2024,” according to MSCI . The good news for long-term investors is that there could well be
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
Genomics Outlook for Disruption Is Rising
“For cancer treatment, living drugs enabled by genetic editing, are forecast to reach a $200B addressable market by 2024,” according to MSCI . The good news for long-term investors is that there could well be